Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cancer Immunology and Immunotherapy

• Publication date

  2005-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00262-004-0575-zPMID 15248031PMCID PMC11032772
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunogenetics of killer-cell immunoglobulin-like receptors.

  2005cited by this paper
• Immunogenetics of killer cell immunoglobulin-like receptors.

  2003cited by this paper
• Association between human leukocyte antigen polymorphism and human papillomavirus 16-positive vulval intraepithelial neoplasia in British women.

  2003cited by this paper
• KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects.

  2003cited by this paper
• Cutting Edge: Susceptibility to Psoriatic Arthritis: Influence of Activating Killer Ig-Like Receptor Genes in the Absence of Specific HLA-C Alleles1

  2002cited by this paper
• Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS

  2002cited by this paper
• Genomic diversity of natural killer cell receptor genes in three populations.

  2001cited by this paper
• Structure of killer cell immunoglobulin‐like receptors and their recognition of the class I MHC molecules

  2001cited by this paper
• Major Histocompatibility Complex Class I–Recognizing Receptors Are Disease Risk Genes in Rheumatoid Arthritis

  2001cited by this paper
• Distribution of natural killer cell immunoglobulin-like receptor sequences in three ethnic groups

  2001cited by this paper
• Frequency of Human Leukocyte Antigen-A 24 Alleles in Patients With Melanoma Determined by Human Leukocyte Antigen-A Sequence-Based Typing

  2000cited by this paper
• NKT cell–mediated repression of tumor immunosurveillance by IL-13 and the IL-4R–STAT6 pathway

  2000cited by this paper
• Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires.

  2000cited by this paper
• Immune suppression and skin cancer development: regulation by NKT cells

  2000cited by this paper
• Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells

  2000cited by this paper
• Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence for recombination.

  1999cited by this paper
• HLA and cancer: from research to clinical impact.

  1998cited by this paper
• Human leucocytic antigens (HLA) in breast cancer.

  1998cited by this paper
• Molecular Analysis of HLA DRB1 and DQB 1 Polymorphism in Italian Melanoma Patients

  1998cited by this paper
• The susceptibility to natural killer cell‐mediated lysis of HLA class I‐positive melanomas reflects the expression of insufficient amounts of different HLA class I alleles

  1998cited by this paper
• Requirement for Vα14 NKT Cells in IL-12-Mediated Rejection of Tumors

  1997cited by this paper
• Implications for immunosurveillance of altered HLA class I phenotypes in human tumours.

  1997cited by this paper
• Natural killer cell lines kill autologous beta2-microglobulin-deficient melanoma cells: implications for cancer immunotherapy.

  1997cited by this paper
• Human diversity in killer cell inhibitory receptor genes.

  1997cited by this paper
• Binding of a soluble p70 killer cell inhibitory receptor to HLA‐B*5101: Requirement for all three p70 immunoglobulin domains

  1997influential reference
• Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors.

  1997cited by this paper
• Molecular genetic analysis of HLA class II alleles in Japanese patients with melanoma.

  1997cited by this paper
• The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions

  1996cited by this paper
• HLA and cancer.

  1996cited by this paper
• Malignant melanoma: relationship of the human leukocyte antigen Class II gene DQB1*0301 to disease recurrence in American Joint Committee on Cancer Stage I or II

  1996cited by this paper
• Molecular and functional phenotypes of melanoma cells with abnormalities in HLA class I antigen expression.

  1996cited by this paper
• Liver NK1.1+ CD4+ alpha beta T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis.

  1996cited by this paper
• Early-appearing tumour-infiltrating natural killer cells play a crucial role in the generation of anti-tumour T lymphocytes.

  1995cited by this paper
• HLA class I antigens in human tumors.

  1995cited by this paper
• The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor

  1995influential reference
• NK3-specific natural killer cells are selectively inhibited by Bw4- positive HLA alleles with isoleucine 80

  1994influential reference
• HLA‐DQB1*0301 association with increased cutaneous melanoma risk

  1994cited by this paper
• HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells.

  1993cited by this paper
• Natural history of HLA expression during tumour development.

  1993cited by this paper
• Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C.

  1993cited by this paper
• Manual for Staging of Cancer

  1992cited by this paper
• Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene.

  1992cited by this paper
• A simple salting out procedure for extracting DNA from human nucleated cells.

  1988cited by this paper
• HLA and cancer.

  1984cited by this paper

• Immunity at maternal–fetal interface: KIR/HLA (Allo)recognition *

  2022cites this paper
• Killer immunoglobulin-like receptor and cancer.

  2022cites this paper
• KIR-HLA gene diversities and susceptibility to lung cancer

  2022cites this paper
• Four novel candidate causal variants for deficient homozygous haplotypes in Holstein cattle

  2022cites this paper
• Landscape and Clinical Significance of Immune Checkpoint in Cutaneous Melanoma

  2021cites this paper
• [Killer immunoglobulin-like receptor and cancer].

  2021cites this paper
• Chimeric antigen receptor T-cell therapy for melanoma

  2021cites this paper
• Investigation of the Effect of KIR–HLA Pairs on Hepatocellular Carcinoma in Hepatitis C Virus Cirrhotic Patients

  2021cites this paper
• Inhibitory KIR2DL2 Gene: Risk for Deep Endometriosis in Euro-descendants

  2020cites this paper
• Killer Cell Immunoglobulin-Like Receptors (KIRs) Genotype and Haplotype Analysis in Iranians with Non-Melanoma Skin Cancers

  2019cites this paper
• Computational KIR copy number discovery reveals interaction between inhibitory receptor burden and survival

  2018cites this paper
• The combination of anti-KIR monoclonal antibodies with anti-PD-1/PD-L1 monoclonal antibodies could be a critical breakthrough in overcoming tumor immune escape in NSCLC

  2018cites this paper
• Disease-association of different killer cell immunoglobulin-like receptors (KIR) and HLA-C gene combinations in reactive arthritis

  2018cites this paper
• Peptide-specific engagement of the activating NK cell receptor KIR2DS1

  2017cites this paper
• The confounding complexity of innate immune receptors within and between teleost species.

  2016cites this paper
• KIR 2D (L1, L3, L4, S4) and KIR 3DL1 protein expression in non-small cell lung cancer

  2016cites this paper
• The Influence of HLA and KIR Genes on Malignant Melanoma Development and Progression

  2016cites this paper
• HLA polymorphism and risk of multiple myeloma

  2016cites this paper
• The prognostic significance of trisomy 4 in acute myeloid leukaemia is dependent on age and additional abnormalities

  2016cites this paper
• Skin Cancer Risk Is Modified by KIR/HLA Interactions That Influence the Activation of Natural Killer Immune Cells.

  2016cites this paper
• Killer cell immunoglobulin-like receptors in immune thrombocytopenia

  2016cites this paper
• HLA y expresión de receptores NK en pacientes con melanoma

  2016cites this paper
• The Impact of KIR Polymorphism on the Risk of Developing Cancer: Not as Strong as Imagined?

  2016cites this paper
• Genetic associations of killer immunoglobulin like receptors and class I human leukocyte antigens on childhood acute lymphoblastic leukemia among north Indians.

  2016cites this paper
• Impact of “Killer Immunoglobulin-Like Receptor /Ligand” Genotypes on Outcome following Surgery among Patients with Colorectal Cancer: Activating KIRs Are Associated with Long-Term Disease Free Survival

  2015cites this paper
• Investigation of Killer Cell Immunoglobulin‐Like Receptors KIR2DL2 and KIR2DL3 Diversity and Identification of Ten Novel KIR2DL3 Alleles in the Chinese Han Population

  2015cites this paper
• Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer.

  2014cites this paper
• Polymorphism of killer cell immunoglobulin-like receptors (KIR) and their HLA ligands in Graves’ disease

  2014cites this paper
• The role of KIR genes and their cognate HLA class I ligands in childhood acute lymphoblastic leukemia.

  2014cites this paper
• The presence of KIR2DS5 confers protection against adult immune thrombocytopenia.

  2014cites this paper
• Emerging role for the killer-cell immunoglobulin-like receptors genotype, in the susceptibility of skin diseases.

  2013cites this paper
• Homozygosity for killer immunoglobin-like receptor haplotype A predicts complete molecular response to treatment with tyrosine kinase inhibitors in chronic myeloid leukemia patients.

  2013cites this paper
• KIR gene variability in cutaneous malignant melanoma: influence of KIR2D/HLA-C pairings on disease susceptibility and prognosis

  2013cites this paper
• [Association between human leukocyte antigen and nasopharyngeal-carcinoma].

  2012cites this paper
• NKG2 Subfamily C (KLRC)

  2012cites this paper
• Killer cell immunoglobulin-like receptor genes in patients with breast cancer

  2012cites this paper
• KIR/HLA gene combinations influence susceptibility to B-cell chronic lymphocytic leukemia and the clinical course of disease.

  2011cites this paper
• Maternal KIR and fetal HLA‐C: a fine balance

  2011cites this paper
• Human leukocyte antigen-B (-Bw6/-Bw4 I80, T80) and human leukocyte antigen-C (-C1/-C2) subgrouping using pyrosequence analysis.

  2011cites this paper
• Muramyl Dipeptide modulates differentiation, maturity of dendritic cells and anti-tumor effect of DC-mediated T cell in acute leukemia children

  2011cites this paper
• Association of KIR-HLA interactions with diseases

  2011cites this paper
• The Role of KIR in Disease

  2010cites this paper
• Receptor systems controlling natural killer cell function are genetically stratified in Europe

  2010cites this paper
• Genetic variations and haplotypes in TIM-3 gene and the risk of gastric cancer

  2010cites this paper
• Identification of four novel KIR2DL2 alleles and two novel KIR2DL3 alleles in an East African population.

  2010cites this paper
• 自然杀伤细胞与癌症——杀伤细胞免疫球蛋白样受体（KIR）的调控

  2010cites this paper
• Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.

  2010cites this paper
• Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.

  2010cites this paper
• Contribution à l'étude des mécanismes de l'alloréactivité des cellules Natural Killer humaines

  2010cites this paper
• Human major histocompatibility complex (MHC)-region gene and haplotype polymorphisms in non-Hodgkin’s lymphoma

  2009cites this paper
• Distribution of Killer Cell Immunoglobulin-like Receptor (KIR) Genotypes in Patients with Familial Mediterranean Fever

  2009cites this paper
• Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.

  2009cites this paper
• HLA associations with nasopharyngeal carcinoma.

  2009cites this paper
• Natural killer cells and cancer: Regulation by the killer cell Ig-like receptors (KIR)

  2009cites this paper
• Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: Decreased NKG2D and increased CD158a receptors on CD3–CD16+ NK cells

  2009cites this paper
• Correlation of effector function with phenotype and cell division after in vitro differentiation of naive MART-1-specific CD8+ T cells.

  2009cites this paper
• The Yin and Yang of HLA and KIR in human disease.

  2008cites this paper
• Killer Cell Immunoglobulin-Like Receptor (KIR) Genotypes in Patients with Recurrent Tonsillitis

  2008cites this paper
• Receptores de células NK (KIR): Estructura, función y relevancia en la susceptibilidad de enfermedades

  2008cites this paper
• KIR2DS5 is associated with leukemia free survival after HLA identical stem cell transplantation in chronic myeloid leukemia patients.

  2008cites this paper
• Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals

  2008cites this paper
• Natural killer cells, killer immunoglobulin‐like receptors and human leucocyte antigen class I in disease

  2007cites this paper
• Analysis of KIR gene frequencies in HLA class I characterised bladder, colorectal and laryngeal tumours.

  2007cites this paper
• Inhibitory KIR–HLA receptor–ligand mismatch in autologous haematopoietic stem cell transplantation for solid tumour and lymphoma

  2007cites this paper
• Killer cell immunoglobulin-like receptors influence the innate and adaptive immune responses.

  2007cites this paper
• MHC class I antigens and immune surveillance in transformed cells.

  2007cites this paper
• Impact of KIR/HLA ligand combinations on immune responses in malignant melanoma

  2006influential citation
• The impact of variation at the KIR gene cluster on human disease.

  2006cites this paper
• The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense.

  2006cites this paper
• Detecting the unusual: natural killer cells.

  2006cites this paper
• An improved RT-PCR method for the detection of killer-cell immunoglobulin-like receptor (KIR) transcripts

  2006cites this paper
• Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans

  2006cites this paper
• KIR and disease: a model system or system of models?

  2006cites this paper
• Susceptibility to myeloid and lymphoid leukemia is mediated by distinct inhibitory KIR-HLA ligand interactions

  2006cites this paper
• Mouse models of efficient and inefficient anti-tumor immunity, with emphasis on minimal residual disease and tumor escape

  2005cites this paper
• HLA class I and class II frequencies in patients with cutaneous malignant melanoma from southeastern Spain: the role of HLA-C in disease prognosis

  2005cites this paper
• Understanding how combinations of HLA and KIR genes influence disease

  2005cites this paper
• CD8 T cells expressing NK associated receptors are increased in melanoma patients and display an effector phenotype

  2005cites this paper